Immuneering Corp. (IMRX)
3.73
-0.08
(-2.10%)
USD |
NASDAQ |
Oct 23, 16:00
3.725
0.00 (0.00%)
After-Hours: 20:00
Immuneering Market Cap : 241.32M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 241.32M |
| October 22, 2026 | 246.50M |
| October 21, 2026 | 241.97M |
| October 20, 2026 | 241.32M |
| October 19, 2026 | 236.79M |
| October 16, 2026 | 232.26M |
| October 15, 2026 | 235.50M |
| October 14, 2026 | 221.27M |
| October 13, 2026 | 230.32M |
| October 12, 2026 | 249.73M |
| October 09, 2026 | 254.91M |
| October 08, 2026 | 241.97M |
| October 07, 2026 | 249.73M |
| October 06, 2026 | 247.79M |
| October 05, 2026 | 261.38M |
| October 02, 2026 | 263.32M |
| October 01, 2026 | 260.73M |
| September 30, 2026 | 264.94M |
| September 29, 2026 | 267.20M |
| September 28, 2026 | 269.14M |
| September 25, 2026 | 276.26M |
| September 24, 2026 | 280.79M |
| September 23, 2026 | 283.37M |
| September 22, 2026 | 298.26M |
| September 21, 2026 | 287.26M |
| Date | Value |
|---|---|
| September 18, 2026 | 289.84M |
| September 17, 2026 | 288.55M |
| September 16, 2026 | 287.90M |
| September 15, 2026 | 287.26M |
| September 14, 2026 | 280.14M |
| September 11, 2026 | 276.26M |
| September 10, 2026 | 295.67M |
| September 09, 2026 | 298.26M |
| September 08, 2026 | 309.25M |
| September 04, 2026 | 311.84M |
| September 03, 2026 | 326.07M |
| September 02, 2026 | 324.78M |
| September 01, 2026 | 313.78M |
| August 31, 2026 | 322.84M |
| August 28, 2026 | 322.84M |
| August 27, 2026 | 337.07M |
| August 26, 2026 | 333.19M |
| August 25, 2026 | 338.37M |
| August 24, 2026 | 335.13M |
| August 21, 2026 | 342.90M |
| August 20, 2026 | 339.66M |
| August 19, 2026 | 344.84M |
| August 18, 2026 | 325.43M |
| August 17, 2026 | 337.72M |
| August 14, 2026 | 327.37M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 1.265 |
| Price | 3.73 |
| Earnings Yield | -27.66% |